Globenewswire·2025-08-18 12:30Core Viewpoint - Impact Biomedical Inc. has received a new patent for a composition and method aimed at controlling infectious diseases, showcasing its commitment to innovative healthcare solutions [1][2][3]. Company Summary - The newly issued U.S. patent No. 12,357,584 B2 is titled "Composition and Method of Controlling Infectious Diseases with Functional Fragrances" and is part of the company's 3F™ technology platform [1][2]. - This patent expands the company's existing patent estate, which includes insect repellent and antimicrobial applications, indicating a strategic focus on addressing unmet healthcare needs [3]. - The CEO of Impact Biomedical emphasized the success of their business model in delivering proprietary technology aimed at improving human healthcare [8]. Product and Technology Summary - The patented compositions consist of plant-derived constituents and fragrances, which have demonstrated unique antimicrobial and antiviral properties [2][4]. - Potential applications of these compositions include their use as disinfectants and treatments for various infectious diseases, targeting pathogens such as E. coli, MRSA, influenza, rhinovirus, and M. tuberculosis [5][6]. - The global infectious disease market is projected to grow significantly, from $21.7 billion in 2024 to $34 billion in 2033, reflecting a compound annual growth rate (CAGR) of 5.77% [7].